The chinchilla microdialysis model for the study of antibiotic distribution to middle ear fluid

Belinda W Y Cheung1, Wei Liu, Ping Ji

  • 1Bioanalytic and Pharmacokinetic Services Laboratory, Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA.

The AAPS Journal
|April 6, 2006
PubMed

Insights

Microdialysis in chinchillas measures unbound antibiotic levels in middle ear fluid (MEF). This model may predict antibiotic efficacy for middle ear infections like acute otitis media.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Otolaryngology

Background:

  • Antibiotic plasma levels may not correlate with efficacy in middle ear infections.
  • Accurate measurement of drug concentrations at the infection site is crucial.
  • A predictive model for middle ear fluid (MEF) drug levels is needed.

Purpose of the Study:

  • Introduce microdialysis for measuring unbound antibiotics in chinchilla MEF.
  • Evaluate MEF penetration of cephalosporin, macrolide, and ketolide antibiotics.
  • Validate the chinchilla microdialysis model for predicting clinical outcomes.

Main Methods:

  • Utilized microdialysis technique in chinchilla models.
  • Measured unbound antibiotic concentrations directly within the middle ear fluid.
  • Compared MEF concentrations with plasma levels and clinical findings.

Main Results:

  • Successfully measured unbound antibiotic concentrations in chinchilla MEF.
  • Demonstrated varying penetration profiles for cephalosporin, macrolide, and ketolide.
  • Preliminary results showed concordance with clinical observations.

Conclusions:

  • The chinchilla microdialysis model is a viable tool for studying antibiotic MEF penetration.
  • This model may aid in predicting antibiotic efficacy for acute otitis media.
  • Further studies can refine the model for broader clinical application.

Related Concept Videos